PT Medco Energi Internasional (MEDC) CMD 2024 Presentation summary
Event summary combining transcript, slides, and related documents.
CMD 2024 Presentation summary
4 Jul, 2025Company overview and strategy
Operates a diversified energy portfolio across oil & gas, clean power, and copper & gold mining, with a strong presence in Southeast Asia and the Middle East.
Growth driven by accretive acquisitions, including successful expansion into Oman and the IPO of Amman Mineral.
Focuses on meeting rising energy demand in fast-growing Southeast Asian economies, leveraging demographic and economic trends.
Strategy centers on expanding oil & gas, investing in renewables and mining, decarbonization, and enhancing shareholder returns.
Maintains a disciplined investment approach, prioritizing high-margin assets and manageable risks.
Oil & gas operations
Holds one of the largest commercial reserves and production bases among Southeast Asian peers, with a 5-year 2P RRR of 233%.
Key assets include South Natuna Sea Block B, Corridor PSC, and Oman blocks, with significant production and new resource opportunities.
Actively monetizes undeveloped resources in Oman, Senoro-Toili, Bangkanai, and Tanzania, targeting production increases and PSC extensions.
Pursues CCS opportunities and climate design, including solar PV installations on offshore facilities.
Maintains unit production cash costs below $10/boe and repays acquisition debt within 2-3 years.
Clean and renewable power
Rapidly expanding clean power portfolio with gas, geothermal, and solar PV projects, targeting over 2 GWp solar capacity by 2030.
Major projects include Riau (275 MW), Sarulla (330 MW), Ijen (110 MW), and the Bulan Island solar export to Singapore (600 MW phase 1).
PLN plans to open up to 60% of new power capacity to private sector, creating significant investment opportunities.
Supports both on-grid and captive power, with cross-border interconnection initiatives.
Latest events from PT Medco Energi Internasional
- EBITDA dropped 4% to $623M in 1H 2025; major Corridor PSC stake acquired.MEDC
Q2 20258 Jan 2026 - Stable EBITDA and higher dividends offset lower net income amid major asset acquisitions.MEDC
Q3 20258 Jan 2026 - Q1 EBITDA rose to $332mn, with strong operations, liquidity, and key project milestones achieved.MEDC
Q1 202517 Jun 2025 - Net income and revenue rose in 9M 2024, supported by asset optimization and strong cash flow.MEDC
Q3 202413 Jun 2025 - Net income surged 68.9% to US$201mn on higher revenue, asset sales, and Oman gain.MEDC
Q2 202413 Jun 2025 - Record 2024 results with net income up 11% and strong growth across all segments.MEDC
Q4 20245 Jun 2025